| Ytd | -41.81% | |
| 1y | -44.77% |
| Open | 4.10 | Prev Close | 4.11 | Low | 4.09 | High | 4.15 | Mkt Cap | 285.91M |
| Vol | 102.71K | Avg Vol | 416.33K | EPS | -2.73 | P/E | -1.51 | Forward P/E | -3.09 |
| Beta | 1.55 | Short Ratio | 14.44 | Inst. Own | 92.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 4.13 | 200-d Avg | 5.46 | 1yr Est | 29.55 |
Needham analyst Ami Fadia maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and lowers the
Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.72) per share which missed the a
On Friday, 422 stocks made new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Before 10 a.m. ET on Tuesday, 128 companies hit new 52-week highs.
During the morning session on Friday, 178 stocks hit new 52-week highs.